Strata Critical Medical, Inc. $SRTA
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Services-Health Services
- Headquarters
- New York, NY
- Fiscal year end
- December 31
- Shares outstanding
- 88,466,806 [10-Q 2026-08-04]
What the company doesAI summary of filing
Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the U.S. healthcare industry that operates one of the nation's largest air transport and surgical services networks for transplant hospitals and organ procurement organizations. The company provides integrated services including air and ground logistics, organ placement, surgical organ recovery, normothermic regional perfusion, organ preservation, perfusion staffing, and equipment solutions for the transplant and cardiovascular surgery industries under the Trinity Medical Solutions and Keystone Perfusion Services brands. Strata generates revenue through contractual arrangements with transplant centers, organ procurement organizations, and hospitals, charging fixed prices per flight hour with fuel surcharges for logistics services and combinations of retainer and per-case fees for clinical services. The company is revenue-generating and operates across two segments: Logistics and Clinical. [10-K 2026-03-03]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $139.89M | −$8.36M | $9.57M | $16.32M | [10-Q 2026-08-04] |
| FY ended Dec 2025 | $197.14M | $41.35M | −$48.91M | $30.97M | [10-K 2026-03-03] |
| FY ended Dec 2024 | $146.82M | −$27.31M | −$2.52M | $18.38M | [10-K 2026-03-03] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-06 | 78,314,023 | [10-Q 2024-11-12] |
| 2025-03-03 | 79,694,028 | [10-K 2025-03-13] |
| 2025-05-05 | 81,017,314 | [10-Q 2025-05-12] |
| 2025-07-29 | 81,695,605 | [10-Q 2025-08-05] |
| 2025-11-03 | 86,366,526 | [10-Q 2025-11-10] |
| 2026-02-24 | 86,989,143 | [10-K 2026-03-03] |
| 2026-04-27 | 86,526,570 | [10-Q 2026-05-06] |
| 2026-07-28 | 88,466,806 | [10-Q 2026-08-04] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-24 | Tomkiel Melissa M. | grant | 177,858 | — | [4 2026-09-25] |
| 2026-09-24 | Tomkiel Melissa M. | other | 90,797 | $5.27 | [4 2026-09-25] |
| 2026-09-24 | Heyburn William A. | grant | 177,858 | — | [4 2026-09-25] |
| 2026-09-24 | Heyburn William A. | other | 98,356 | $5.27 | [4 2026-09-25] |
| 2026-09-08 | Verdetto Louis R. | other | 5,697 | $5.31 | [4 2026-09-10] |
| 2026-09-08 | Wunsch Scott M | other | 5,711 | $5.31 | [4 2026-09-10] |
| 2026-09-08 | Cohen Amir | other | 4,645 | $5.31 | [4 2026-09-10] |
| 2026-09-08 | Tomkiel Melissa M. | other | 29,730 | $5.31 | [4 2026-09-10] |
| 2026-09-08 | Heyburn William A. | other | 31,671 | $5.31 | [4 2026-09-10] |
| 2026-08-10 | Love Reginald | sell | 5,091 | $5.75 | [4 2026-08-13] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-20 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-04 | 10-Q | Quarterly report |
| 2026-08-04 | 8-K | Results of operations |
| 2026-07-08 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-06-17 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-06-03 | 8-K | Shareholder vote results |
| 2026-05-08 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-05-06 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Results of operations |
| 2026-04-30 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-04-16 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-04-14 | DEF 14A | Proxy statement |
Alerts for $SRTA
Email me when Strata Critical Medical, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.